CVS Health Corporation $CVS Stock Sold by Keybank National Association OH

Keybank National Association OH trimmed its position in CVS Health Corporation (NYSE:CVS) by 10.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 87,894 shares of the pharmacy operator’s stock after selling 10,421 shares during the period. Keybank National Association OH’s holdings in CVS Health were worth $7,532,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. bought a new stake in CVS Health in the second quarter valued at approximately $12,747,462,000. State Street Corp raised its holdings in CVS Health by 26.3% in the second quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock worth $7,751,205,000 after purchasing an additional 15,604,883 shares during the period. Wellington Management Group LLP boosted its position in shares of CVS Health by 49.8% during the second quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock worth $3,496,725,000 after purchasing an additional 11,233,381 shares in the last quarter. Bank of America Corp DE boosted its position in shares of CVS Health by 148.0% during the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after purchasing an additional 13,836,701 shares in the last quarter. Finally, Pzena Investment Management LLC acquired a new position in shares of CVS Health in the 2nd quarter valued at $1,217,558,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Trending Headlines about CVS Health

Investors following CVS have been watching these headlines:

• Positive Sentiment: CVS reported quarterly adjusted earnings of $2.09 per share, beating the $1.65 consensus estimate, while revenue rose 5.4% year over year to $108.4 billion. The earnings beat and growth support the case for improved operating performance. Article: CVS Beat Earnings by 27% and Split in Two
• Positive Sentiment: CVS’s planned 2028 split could sharpen strategic focus and improve capital allocation, potentially unlocking value in its businesses. Wells Fargo kept an “overweight” rating and sees its $112 price target as implying upside, despite lowering the target from $123. Article: Can CVS Health’s 2028 Split Unlock Value Despite Execution Risks?
• Negative Sentiment: The split is not a guaranteed catalyst: coverage highlights separation costs and execution risks, while Aetna’s recovery and stronger pharmacy profits are weighed against PBM pressures and declining membership. Senator Elizabeth Warren has also criticized the plan, suggesting political scrutiny may continue. Article: Is CVS Stock Worth Buying as Aetna Recovers but PBM Risks Persist?

Insider Activity at CVS Health

In other news, EVP Prem Shah purchased 23,855 shares of the business’s stock in a transaction dated Friday, November 6th. The shares were bought at an average cost of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the acquisition, the executive vice president directly owned 88,516 shares in the company, valued at approximately $7,425,607.24. This trade represents a 36.89% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.85% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CVS. Robert W. Baird set a $107.00 price objective on shares of CVS Health in a research report on Thursday, August 6th. UBS Group reduced their target price on CVS Health from $118.00 to $107.00 and set a “buy” rating on the stock in a report on Thursday, November 5th. Barclays lowered their price target on CVS Health from $108.00 to $107.00 and set an “overweight” rating for the company in a report on Thursday, November 5th. Evercore reaffirmed an “outperform” rating on shares of CVS Health in a research report on Wednesday, November 4th. Finally, Wells Fargo & Company cut their price objective on CVS Health from $123.00 to $112.00 and set an “overweight” rating on the stock in a report on Thursday. Twenty-three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $107.79.

CVS Health Stock Up 0.2%

Shares of CVS stock opened at $89.69 on Friday. The firm has a fifty day moving average of $89.81 and a 200-day moving average of $89.00. The company has a quick ratio of 0.66, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68. The company has a market capitalization of $114.76 billion, a price-to-earnings ratio of 10.75, a P/E/G ratio of 0.78 and a beta of 0.58.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 4th. The pharmacy operator reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $1.65 by $0.44. The business had revenue of $108.40 billion for the quarter, compared to analyst estimates of $104.72 billion. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The firm’s quarterly revenue was up 5.4% on a year-over-year basis. During the same period last year, the business posted $1.60 earnings per share. As a group, equities research analysts predict that CVS Health Corporation will post 8.26 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were paid a $0.6650 dividend. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.0%. CVS Health’s dividend payout ratio (DPR) is currently 30.97%.

CVS Health Profile

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.